A phase I study to evaluate the safety, pharmacokinetics (PK), and pharmacodynamics (PD) of ganaxolone IV in healthy volunteers
Phase of Trial: Phase I
Latest Information Update: 11 Apr 2017
At a glance
- Drugs Ganaxolone (Primary)
- Indications Status epilepticus
- Focus Adverse reactions; Pharmacokinetics
- 11 Apr 2017 Results presented at the 6th London-Innsbruck Colloquium on Status Epilepticus and Acute Seizures 2017, according to a Marinus Pharmaceuticals media release.
- 03 Nov 2016 Status changed from recruiting to completed, as per Marinus Pharmaceuticals media release.
- 19 Oct 2016 Results were presented at the 141st Annual Meeting of the American Neurological Association (ANA), Marinus Pharmaceuticals media release.